These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17624051

  • 1. Chemotherapy-induced mucositis: focusing on diarrhea.
    Wisinski K, Benson A.
    J Support Oncol; 2007 Jun; 5(6):270-1. PubMed ID: 17624051
    [No Abstract] [Full Text] [Related]

  • 2. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.
    Stringer AM, Gibson RJ, Bowen JM, Logan RM, Yeoh AS, Keefe DM.
    J Support Oncol; 2007 Jun; 5(6):259-67. PubMed ID: 17624050
    [Abstract] [Full Text] [Related]

  • 3. Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis.
    Wang X, Gao J, Qian L, Gao J, Zhu S, Wu M, Zhang Y, Guan W, Ye H, Yu Y, Han W.
    Anticancer Drugs; 2015 Jan; 26(1):35-45. PubMed ID: 24999837
    [Abstract] [Full Text] [Related]

  • 4. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
    Keefe DM, Elting LS, Nguyen HT, Grunberg SM, Aprile G, Bonaventura A, Selva-Nayagam S, Barsevick A, Koczwara B, Sonis ST.
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
    [Abstract] [Full Text] [Related]

  • 5. Positive effects of oral β-glucan on mucositis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy.
    Karaca H, Bozkurt O, Ozaslan E, Baldane S, Berk V, Inanc M, Duran AO, Dikilitas M, Er O, Ozkan M.
    Asian Pac J Cancer Prev; 2014 Oct; 15(8):3641-4. PubMed ID: 24870771
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ, Han XD, Wang Y, Yuan KL, Jin ZM, Di JZ, Yan J, Pan Y, Zhang P, Huang XY, Wang ZG, Zheng Q.
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [Abstract] [Full Text] [Related]

  • 7. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation.
    Lee CS, Ryan EJ, Doherty GA.
    World J Gastroenterol; 2014 Apr 14; 20(14):3751-61. PubMed ID: 24744571
    [Abstract] [Full Text] [Related]

  • 8. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
    Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW.
    Clin Nutr; 2007 Feb 14; 26(1):57-62. PubMed ID: 16949180
    [Abstract] [Full Text] [Related]

  • 9. Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment.
    Lenfers BH, Loeffler TM, Droege CM, Hausamen TU.
    Ann Oncol; 1999 Oct 14; 10(10):1251-3. PubMed ID: 10586346
    [Abstract] [Full Text] [Related]

  • 10. [Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy].
    Cai X, Xue P, Song WF, Hu J, Gu HL, Yang HY, Wang LW.
    Zhonghua Zhong Liu Za Zhi; 2012 Jan 14; 34(1):39-43. PubMed ID: 22490854
    [Abstract] [Full Text] [Related]

  • 11. Protective effect and potential mechanisms of Wei-Chang-An pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice.
    Chen Y, Zheng H, Zhang J, Wang L, Jin Z, Gao W.
    J Ethnopharmacol; 2016 Aug 22; 190():200-11. PubMed ID: 27240747
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracil.
    Javle MM, Cao S, Durrani FA, Pendyala L, Lawrence DD, Smith PF, Creaven PJ, Noel DC, Iyer RV, Rustum YM.
    Clin Cancer Res; 2007 Feb 01; 13(3):965-71. PubMed ID: 17289892
    [Abstract] [Full Text] [Related]

  • 13. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
    Klautke G, Fietkau R.
    Strahlenther Onkol; 2002 Mar 01; 178(3):163-4. PubMed ID: 11962194
    [No Abstract] [Full Text] [Related]

  • 14. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y, Sun YJ, Zhao H, Guo YW, Lin F, Cai X, Tang XC, Tang LN, Zhang W.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract] [Full Text] [Related]

  • 15. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Pestalozzi BC.
    N Engl J Med; 2001 Jan 25; 344(4):306; author reply 306-7. PubMed ID: 11191662
    [No Abstract] [Full Text] [Related]

  • 16. Neomycin as secondary prophylaxis for irinotecan-induced diarrhea.
    Schmittel A, Jahnke K, Thiel E, Keilholz U.
    Ann Oncol; 2004 Aug 25; 15(8):1296. PubMed ID: 15277273
    [No Abstract] [Full Text] [Related]

  • 17. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C, George T, Yothers G.
    J Natl Cancer Inst; 2011 Jan 05; 103(1):4-5. PubMed ID: 21123834
    [No Abstract] [Full Text] [Related]

  • 18. Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model.
    Yoneda J, Nishikawa S, Kurihara S.
    BMC Cancer; 2021 Dec 18; 21(1):1343. PubMed ID: 34922485
    [Abstract] [Full Text] [Related]

  • 19. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat.
    Abalo R, Uranga JA, Pérez-García I, de Andrés R, Girón R, Vera G, López-Pérez AE, Martín-Fontelles MI.
    Neurogastroenterol Motil; 2017 Mar 18; 29(3):. PubMed ID: 27686064
    [Abstract] [Full Text] [Related]

  • 20. [Management of chemotherapy induced diarrhea].
    Schultz M, Schölmerich J, Kullmann F.
    Z Gastroenterol; 2004 Jun 18; 42(6):527-38. PubMed ID: 15190449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.